Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Controlled Trial on the Homocysteine-Lowering Effects of Different Doses of Folic Acid Among Patients With Hypertension According to Methylenetetrahydrofolate Reductase C677T Genotypes

NCT03472508 is registered in ClinicalTrials.gov with Shenzhen Ausa Pharmed Co.,Ltd as lead sponsor.

NCT NCT03472508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03472508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Controlled Trial on the Homocysteine-Lowering Effects of Different Doses of Folic Acid Among Patients With Hypertension According to Methylenetetrahydrofolate Reductase C677T Genotypes
Lead sponsor
Shenzhen Ausa Pharmed Co.,Ltd
Phase
Phase 4
Overall status
Unknown status
Start date
March 20, 2018
Completion date
June 30, 2019
Enrollment
3,600 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension